CEO: John Fowler

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.


Key numbers

Market Capitalization:48429260
Shares Outstanding: 19142000
Float: 11637091.77
Next Earning Date:2020-03-31
TTm EPS: -1.6417
TTm Dividend Rate:
200 days moving average:10.68
50 days moving average: 3.27
One day percent Change: 0.3



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,